Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling

Journal: Nature Immunology

Published: 2019-10-21

DOI: 10.1038/s41590-019-0515-x

Affiliations: 19

Authors: 19

Go to article
Institutions Share
Department of Pediatric Oncology, DFCI, United States of America (USA) 0.12
Department of Cancer Immunology and Virology, DFCI, United States of America (USA) 0.11
Harvard Department of Genetics and Complex Diseases, United States of America (USA) 0.11
Harvard Department of Microbiology, United States of America (USA) 0.08
Harvard Department of Immunology, United States of America (USA) 0.08
Department of Cancer Immunology, Genentech, Inc., United States of America (USA) 0.08
Broad Institute of MIT and Harvard, United States of America (USA) 0.08
Evergrande Center for Immunologic Diseases, United States of America (USA) 0.07
Harvard Division of Medical Sciences (DMS), United States of America (USA) 0.05
Department of Cancer Biology, DFCI, United States of America (USA) 0.05
Harvard Department of Cell Biology, United States of America (USA) 0.05
University Hospital Bonn (UKB), Uni Bonn, Germany 0.03
Department of Immuno-oncology, NIBR, United States of America (USA) 0.03
Institute of Experimental Immunology (IEI), Uni Bonn, Germany 0.02
Division of Hematology/Oncology, BCH, United States of America (USA) 0.01
Merck Research Laboratories (MRL) - Boston, United States of America (USA) 0.01
Department of Pathology, BWH, United States of America (USA) 0.01
Neon Therapeutics, United States of America (USA) 0.01

Return